Ketamine breathing treatment for severe asthma attacks in children
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests whether giving ketamine as a mist through a nebulizer can help children with severe asthma attacks breathe easier. It is for children aged 1 to 13 who have already received standard treatments but still have severe symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 1 and 13 years old.
- Your child is having a severe asthma attack that standard treatments haven't fully relieved.
- Your child has not had a bad reaction to ketamine before.
- Your child does not have serious heart problems or high blood pressure.
- Your child does not have severe sleep apnea.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a nebulized medication called ketamine to standard asthma treatment helps people having a moderate to severe asthma attack breathe better. Ketamine is usually used as an anesthetic, but in this form it may help relax the airways.
This trial tests if a ketamine mist you breathe in can help treat moderate to severe depression. It is for adults who are not helped enough by other treatments.
This study tests whether giving ketamine during heart surgery helps protect the brain in young children. It is for children aged 1 month to 5 years who are having surgery to fix a hole in the wall between the heart chambers (atrial or ventricular septal defect).
This study tests whether ketamine, a sedative and painkiller, works better than usual sedatives in ICU patients who need help breathing. If you qualify, taking part may help reduce the amount of other sedatives you need.
This study tests whether low-dose ketamine infusions can reduce depressive symptoms in patients staying in the intensive care unit for at least 6 days. Ketamine is a medication that may work differently than standard antidepressants and could provide faster relief.
This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.
Hear when a new Asthma Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.